Risk factors for repeated percutaneous transluminal angioplasty of hemodialysis vascular access after initial intervention

CONCLUSIONS: Among the patients undergoing hemodialysis, the use of antiplatelet agents was associated with a lower risk of re-PTA. Therefore, the use of antiplatelet drugs may reduce the rates of re-PTA and help in maintaining the patency of vascular access.PMID:38545905 | DOI:10.1177/17085381241241362

Source: Vascular - March 28, 2024 Category: Surgery Authors: Bin Tang Yuwan Xiong Yingxue Zhong Guojun Hao Yuanhao Liu Wei He Tak-Sui Wong Zongchao Yu Bo Hu Source Type: research